Innovating Works

DESTINA GENOMICA

Activa
diaRNAgnosis: A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids DESTINA GENOMICA tramitó un H2020: Circulating cell-free ribonucleic acids (ccfRNAs) represent an emerging and important class of molecules, able to provide significant clinical relevance as novel screening, prognostic and therapy moni...
2021-01-01 | Financiado
PTQ2020-011388: Implementación y validación de la tecnología DGL-TechTM a través de plataformas de tests rápidos y de bajo coste para el diagnóstico de enfermedades infecciosas DESTINA GENOMICA tramitó un AEI: 2020-01-01 | Financiado
ARREST-TB: Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis THE UNIVERSITY OF EDINBURGH tramitó un H2020: This visionary project addresses the key needs of patients, clinicians and the World Health Organisations stated deliverables of affordable, reliable and point-of-care molecular TB diagnostics, with t...
2019-01-01 | Financiado
Halo: Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets ROYAL COLLEGE OF SURGEONS IN IRELAND tramitó un H2020: The aim of this project is to expand upon a newly discovered platform reaction by developing new routes to Active Pharmaceutical Ingredients (APIs) Tolterodine and Ezetimibe and other advanced interme...
2017-01-01 | Financiado
PTQ-16-08597: Desarrollo de kit de detección de ácidos nucleicos in real time con química dínamica ChemNAT DESTINA GENOMICA tramitó un AEI: 2016-01-01 | Financiado
miRNA-DisEASY: microRNA biomarkers in an innovative biophotonic sensor kit for high-specific diagnosis OPTOELETTRONICA ITALIA SRL tramitó un H2020: Since 2001’s discovery of microRNAs (miRNAs) in humans, progress in genomics and transcriptomics has increased our comprehension of gene expression regulation. miRNAs are small, noncoding RNA molecule...
2015-12-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.